drugset / Trial / NCT04173845
Double Randomized and Placebo Controlled Trail of Tianqi Pingchan Granule to Prevent Levodopa-Induced Dyskinesia
Unknown
150 enrolled
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Affiliated Hospital of Nanjing University of Chinese Medicine · collabHuai'an First People's Hospital · collabSuqian Branch, Jiangsu Province Hospital · collabXin Hua Hospital of Zhejiang Province · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
A randomized, double-blind, placebo-controlled multicenter clinical trial was used to observe the effectiveness, safety and side effects of Tianqi Pingzhan Granule in the prevention of levodopa induced dyskinesia, so as to determine the clinical efficacy of Tianqi Pingzhan Granule in the prevention of levodopa induced dyskinesia.
Timeline
- Start
- 2019-09-01
- Primary completion
- 2020-12-31
- Completion
- 2021-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tianqi Pingchan Granule | Traditional medicine (herbal / TCM) | — | — |